Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Henry Schein to Present at the Morgan Stanley Global Healthcare Conference

September 12, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Sept. 12, 2011 /- Henry Schein, Inc., (NASDAQ: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that Steven Paladino, Executive Vice President and Chief Financial Officer, Henry Schein, will present at...

Analyses Find Type 2 Diabetes Patients Treated with BYDUREONâ„¢ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011

September 12, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

LISBON, Portugal, Sept. 12, 2011 /- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) today announced new analyses from the DURATION-3 and -4 trials demonstrating patients treated with the investigational medication...

New Data on EMA401 in Model of Diabetic Neuropathy Presented at 21st Annual NEURODIAB Meeting

September 12, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, September 12, 2011 /-   EMA401 Shown to Improve Nerve and Neurovascular Function Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy....


Advisory Committee Notice of Meeting: October 13, 2011 - Circulatory System Devices Panel of the Medical Devices Advisory Committee

September 11, 2011 9:30 pm | by U.S. Food & Drug Administration | News | Comments

Confirmed Scheduled Advisory Meetings

Ventana Medical Systems, Inc. Unveils High-throughput Slide Scanner for Digital Pathology

September 11, 2011 12:38 pm | by Bio-Medicine.Org | News | Comments

GRAPEVINE, Texas, Sept. 11, 2011 /- Ventana Medical Systems, Inc . (Ventana), a member of the Roche Group, unveiled the VENTANA iScan HT slide scanner prototype before a packed audience at the 2011 College of American Pathologists (CAP) annual meeting. The VENTANA iScan HT slide...

Core Essence Orthopaedics Unveiled New Flexor Tendon Repair System at ASSH 2011

September 11, 2011 11:40 am | by Bio-Medicine.Org | News | Comments

FORT WASHINGTON, Pa., Sept. 10, 2011 /- Core Essence Orthopaedics, Inc., a medical device company focused on orthopaedic soft tissue and skeletal repair of the extremities, has introduced their novel, surgeon-designed PONTiS™ Knotless Endotendonous Repair System at the 66th Annual...

Questcor Provides Updated New Paid Prescription Trends

September 10, 2011 10:38 am | by Bio-Medicine.Org | News | Comments

ANAHEIM, Calif., Sept. 10, 2011 /- Commencing on September 12, 2011, Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) will utilize an updated presentation for meetings with investors. This presentation was filed under Form 8-K with the SEC on Friday, September 9 at 3 p.m. PST and will be...

Tax Will Drive Device Makers Overseas, AdvaMed Predicts

September 9, 2011 3:31 pm | by U.S. Food & Drug Administration | News | Comments

Devicemakers may flee overseas if the U.S. implements a recently enacted tax on prescription devices, AdvaMed says. The nation could lose thousands of device industry jobs and see demand shrink for products whose cost rises as a result of the excise tax, according to a report the trade...


CDRH Gets Slight Raise, Field Cut as Senate Budget Numbers Harden

September 9, 2011 3:30 pm | by U.S. Food & Drug Administration | News | Comments

FDA device regulators would get marginally more money in fiscal 2012 than in fiscal 2011, but nearly $7 million less than the agency sought.

European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)

September 9, 2011 1:38 pm | by Bio-Medicine.Org | News | Comments

BRUSSELS, September 9, 2011 /- The Board of the European Fine Chemicals Group (EFCG) is delighted to announce that today it agreed to ratify the proposal of the US Food and Drug Administration (FDA) to put forward a legislative package, designed with the help of EFCG and US industry...

Smith & Nephew Showcases Strong Data at the Clinical Symposium on Advances in Skin & Wound Care Conference

September 9, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

ST. PETERSBURG, Fla., Sept. 9, 2011 /- The Advanced Wound Management division of Smith & Nephew (LSE: SN; NYSE: SNN ) today announced results from 11 studies on a range of products and therapies from their ALLEVYN * , ACTICOAT * , IODOSORB * and RENASYS* wound care portfolio. The...

Physicians Aren't Immune to Feeling Entitled

September 9, 2011 8:39 am | by Diagnostic Imaging | News | Comments

During the national debate over our ballooning debt, there has been a fair amount of talk about entitlements. In that context, “entitlements” refers to social programs such as Medicaid, Social Security, disability, and the like - programs intended to help members of society who are less...

Roche Starts Early Stage Clinical Trial in Down Syndrome

September 9, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

BASEL, Switzerland and NUTLEY, N.J., Sept. 9, 2011 /- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the initiation of its first Phase 1 clinical trial to investigate the safety and tolerability of a molecule designed to address the cognitive and behavioral deficits associated with...


Cardica's Cardiac Anastomosis Device Featured in Clinical Presentation on Robotic Cardiac Bypass Procedures

September 9, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Sept. 9, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today reported that its C-Port® Flex-A® Anastomosis System will be featured in a clinical presentation to cardiothoracic surgeons this afternoon at the East Carolina Heart Institute-International Society for...

Abaxis, Inc. to Present at CL King's 9th Annual Best Ideas Conference 2011

September 9, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., Sept. 9, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at CL King's 9th Annual Best Ideas Conference 2011 on...

Cardica Signs Distribution Agreement for MicroCutter in Japan(2)

September 9, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Sept. 8, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that it has signed a distribution agreement with Century Medical, the company's distribution partner for its PAS-Port® Proximal Anastomosis System in Japan, for Cardica's planned MicroCutter...

Meeting Materials for the Obstetrics and Gynecology Devices Panel Meeting held on September 8-9, 2011

September 9, 2011 4:31 am | by U.S. Food & Drug Administration | News | Comments

The Obstetrics and Gynecology Devices Panel reviews and evaluates data concerning the safety and effectiveness of marketed and investigational in vitro devices for use in clinical laboratory medicine including clinical and molecular genetics...

"Scientific Oktoberfest" Draws the Worldwide Leading Researchers in the Field of Chemical Biology to Munich

September 9, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

MUNICH, September 9, 2011 /- The "Scientific Oktoberfest" will be this year's meeting point for some of the internationally most distinguished researchers in the field of Chemical Biology. The so-called "CIPS M Fest of Chemical Biology" will be held from the 15 th to the 16 th of...

Pro-Dex, Inc. Announces Fiscal 2011 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast

September 9, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 8, 2011 /- PRO-DEX, INC. (Nasdaq: PDEX ) invites investors and analysts to listen to a broadcast review of the Company's fiscal 2011 fourth quarter and full-year financial results. The conference call is scheduled to be broadcast live over the internet on...

Rottenstein Law Group Produces Videos to Inform Public About Paxil History, Dangers, and Litigation

September 9, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 9, 2011 /- The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the antidepressant Paxil, has produced a series of brief videos specifically intended to educate the public about the history of Paxil, possible dangers to...

Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions

September 8, 2011 6:34 pm | by Bio-Medicine.Org | News | Comments

HAYWARD, Calif., Sept. 8, 2011 /- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that the U.S. Patent and Trademark Office has given the Company a Notice of Allowance for...

Rescheduled Webcast: Isis Pharmaceuticals Hosts Dr. John Kastelein to Review Mipomersen Long-term Data Recently Presented at ESC Congress 2011

September 8, 2011 6:33 pm | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 8, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announces the following webcast:What: Data from Mipomersen's Open-Label Extension Study presented at ESCWhen: Monday, September 12, 2011 at 12:00 p.m. ET / 9:00 a.m. PTWhere: www.isispharm.comHow: Live...

Metabolic Solutions Development Company Reports Positive Top-Line Results From Phase 2a Study of Its Second Compound to Treat Type 2 Diabetes

September 8, 2011 12:37 pm | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich., Sept. 8, 2011 /- Metabolic Solutions Development Company, LLC (MSDC) confirmed today the potential of MSDC-0602 to achieve significant glucose control in type 2 diabetes patients and increase insulin sensitivity based on preliminary analysis from its Phase 2a trial of...

MedInformatix' Practice Management and Electronic Medical Records Simplifies Texas Dermatology Practice's Current and Future Operations

September 8, 2011 10:41 am | by Bio-Medicine.Org | News | Comments

FLOWER MOUND, Texas, Sept. 8, 2011 /- There often comes a time when IT's forward march brings a medical practice to a crossroads, a fork in the road where both directions lead to the same destination though not equally efficiently or cost effectively. Such was the case for Flower Mound...

Thermo Fisher to cut 122 NH jobs

September 8, 2011 10:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Thermo Fisher Scientific Inc. is cutting 122 jobs in New Hampshire – including 109 in Newington and 13 in Portsmouth – in a move to "increase efficiencies" for the Waltham-based life sciences equipment supplier, a spokesperson said.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.